Pharmaceutical compositions containing octreotide and excipients for oral or rectal administration
AssigneeSandoz Ltd.
InventorsJacky Vonderscher, Joachim Franz, Michel Steiger, Karl Hornung
Life of this patent
Estimating the term…
Abstract
Polypeptide compositions for inter alia SMS are provided containing a monosaccharide/sugar alcohol and/or a polyoxyalkylene ether having enhanced resorption properties for oral or rectal administration.
Claims27
A pharmaceutical composition comprising octreotide and an excipient selected from the group consisting of a) a, monosaccharide, b) a sugar alcohol, c) a monosaccharide and a polyoxyalkylene ether, and d) a sugar alcohol and a polyoxyalkylene ether, and said composition being adapted for gastro-intestinal resorption by oral or rectal administration.
A pharmaceutical composition comprising octreotide and an excipient selected from the group consisting of a) a monosaccharide, b) a sugar alcohol, c) a monosaccharide and a polyoxyalkylene ether, and d) a sugar alcohol and a polyoxyalkylene ether, and said composition being adapted for gastro-intestinal resorption by oral or rectal administration and having a relative bioavailability of said octreotide, in blood plasma up to 12 hours after administration, of at least 160% by oral or rectal administration compared with 100% by oral or rectal administration of said octreotide alone.
A pharmaceutical suppository composition comprising octreotide, a polyoxyalkylene ether excipient, and a suppository base, and said composition being adapted for gastro-intestinal resorption by rectal administration.
Dependencies are inferred from the claim text.